Drugs / [123I]I-DARPIN-Ec1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06386653 | Apr → Dec 2024 | lung cancer, ovarian cancer | Tomsk National Research Medical Center of the Russian Academy of Sciences | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [123I]I-DARPIN-Ec1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06386653 ↗ |
| Route | Intravenous | “A single intravenous injection of \[123I\]I-DARPIN-Ec1” NCT06386653 ↗ |